Skip to main content
Pila Pharma AB (publ) (STO:PILA)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.136
-0.046 (-3.89%)
Mar 9, 2026, 4:41 PM CET

Pila Pharma AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-16.86-11.24-9.93-26.78-17.21
Upgrade
Depreciation & Amortization
1.081.081.080.020.02
Upgrade
Other Operating Activities
6.23.083.517.897.92
Upgrade
Change in Accounts Receivable
-0.130.160.07-0.06-0.16
Upgrade
Change in Accounts Payable
-0.15-0.790.82-00.14
Upgrade
Change in Other Net Operating Assets
0.68-0.11-0.39-0.16-0.07
Upgrade
Operating Cash Flow
-9.19-7.82-4.85-9.09-9.36
Upgrade
Long-Term Debt Issued
--1.5--
Upgrade
Total Debt Issued
--1.5--
Upgrade
Short-Term Debt Repaid
-----0.5
Upgrade
Long-Term Debt Repaid
---1.5--
Upgrade
Total Debt Repaid
---1.5--0.5
Upgrade
Net Debt Issued (Repaid)
-----0.5
Upgrade
Issuance of Common Stock
32.47107.066.9248.54
Upgrade
Other Financing Activities
-12.28-3.24-3.5-18.8-12.37
Upgrade
Financing Cash Flow
20.196.763.56-11.8835.67
Upgrade
Net Cash Flow
11.01-1.06-1.29-20.9726.3
Upgrade
Levered Free Cash Flow
-3.66-4.66-2.44-5.76-5.88
Upgrade
Unlevered Free Cash Flow
-3.52-4.66-2.42-5.76-5.86
Upgrade
Change in Working Capital
0.4-0.740.5-0.22-0.09
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.